Patterns of consultation and treatment of patients with hepatocellular carcinoma presenting to a large academic medical center in the US

J Gastrointest Surg. 2013 Sep;17(9):1600-8. doi: 10.1007/s11605-013-2253-y. Epub 2013 Jun 19.

Abstract

Background: Management of hepatocellular carcinoma (HCC) often involves many subspecialist providers, as well as a broad range of treatment options. This study sought to evaluate referral and treatment patterns among patients with HCC at a large academic medical center.

Methods: Data from our cancer registry between 2003-2011 were abstracted on 394 patients who were primarily diagnosed/treated for HCC at Johns Hopkins Hospital (JHH); data on patients who were diagnosed/treated with HCC elsewhere and who received secondary treatment at JHH (n = 391) were also abstracted for comparison purposes.

Results: Among the main cohort, the most common specialties to be consulted were surgery (n = 225, 57.1%), gastroenterology (n = 225, 57.1%), and interventional radiologist (n = 206, 52.3%), while only 96 (24.4%) were referred to medical oncology. Factors associated with surgical consultation included younger age (odds ratio (OR) 3.35, 95% CI 1.62-6.92), tumor size <5 cm (OR 1.82, 1.09-3.02), and unilobar disease (OR 2.94, 1.31-6.59) (all P < 0.05). Patients initially diagnosed/treated elsewhere had larger tumors (4 vs. 6 cm), bilateral disease (19.2 vs. 26.8%), and were more likely to be seen by interventional radiology (all P < 0.05) CONCLUSIONS: Most patients were seen by surgeons, gastroenterologists, or interventional radiologists, with only a minority being seen by medical oncologists. Referral patterns depended on patient-level factors, as well as extent of disease.

Publication types

  • Evaluation Study

MeSH terms

  • Academic Medical Centers / organization & administration
  • Academic Medical Centers / statistics & numerical data*
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Hepatocellular* / diagnosis
  • Carcinoma, Hepatocellular* / mortality
  • Carcinoma, Hepatocellular* / therapy
  • Combined Modality Therapy
  • Female
  • Gastroenterology
  • General Surgery
  • Hepatectomy
  • Humans
  • Liver Neoplasms* / diagnosis
  • Liver Neoplasms* / mortality
  • Liver Neoplasms* / therapy
  • Logistic Models
  • Male
  • Maryland
  • Medical Oncology
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Proportional Hazards Models
  • Radiology, Interventional
  • Referral and Consultation / statistics & numerical data*
  • Registries
  • Retrospective Studies

Substances

  • Antineoplastic Agents